264 related articles for article (PubMed ID: 16547967)
1. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis.
Muthian G; Raikwar HP; Rajasingh J; Bright JJ
J Neurosci Res; 2006 May; 83(7):1299-309. PubMed ID: 16547967
[TBL] [Abstract][Full Text] [Related]
2. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
Bright JJ; Du C; Sriram S
J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis.
Muthian G; Raikwar HP; Johnson C; Rajasingh J; Kalgutkar A; Marnett LJ; Bright JJ
J Clin Immunol; 2006 Jan; 26(1):73-85. PubMed ID: 16418805
[TBL] [Abstract][Full Text] [Related]
4. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.
Muthian G; Bright JJ
J Clin Immunol; 2004 Sep; 24(5):542-52. PubMed ID: 15359113
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Natarajan C; Bright JJ
Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
Natarajan C; Bright JJ
J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
Bright JJ; Sriram S
J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
9. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3).
Mattner F; Smiroldo S; Galbiati F; Muller M; Di Lucia P; Poliani PL; Martino G; Panina-Bordignon P; Adorini L
Eur J Immunol; 2000 Feb; 30(2):498-508. PubMed ID: 10671205
[TBL] [Abstract][Full Text] [Related]
11. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
Spanier JA; Nashold FE; Olson JK; Hayes CE
J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
[TBL] [Abstract][Full Text] [Related]
13. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
Natarajan C; Sriram S; Muthian G; Bright JJ
Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
[TBL] [Abstract][Full Text] [Related]
14. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
[TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
Pedersen LB; Nashold FE; Spach KM; Hayes CE
J Neurosci Res; 2007 Aug; 85(11):2480-90. PubMed ID: 17600374
[TBL] [Abstract][Full Text] [Related]
16. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
[TBL] [Abstract][Full Text] [Related]
17. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
18. Setaria digitata secreted filarial lipids modulate IL-12 signaling through JAK-STAT pathway leading to the development of Th1 response.
Muthian G; Pradeep CG; Sargapradeep K; Kaleysaraj R; Bright JJ
Exp Parasitol; 2006 Nov; 114(3):193-203. PubMed ID: 16647056
[TBL] [Abstract][Full Text] [Related]
19. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
20. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.
Yoshida H; Kimura A; Fukaya T; Sekiya T; Morita R; Shichita T; Inoue H; Yoshimura A
Biochem Biophys Res Commun; 2012 Feb; 418(2):234-40. PubMed ID: 22252297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
